» Articles » PMID: 18474185

Stem Cell Regeneration of Degenerated Intervertebral Discs: Current Status

Overview
Date 2008 May 14
PMID 18474185
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Low back pain (LBP) is one of the most common musculoskeletal conditions, and intervertebral disc (IVD) degeneration is associated with most cases. Although many treatment options are available, they focus on the removal of symptoms rather than repair of the degenerate tissue. However, there is a growing interest in the potential of cell-based tissue engineering strategies for regeneration of the damaged IVD. To achieve this, investigators are now focusing on the use of mesenchymal stem cells (MSCs), which offer several advantages over more mature cell types. A number of problems must be overcome for MSC-based IVD regeneration to be successful, including determining a method for the differentiation of stem cells into nucleus pulposus-like cells. Although this is still a relatively new field, it offers huge potential for the clinical treatment of IVD degeneration and LBP in the future.

Citing Articles

Self-healing hydrogels loaded with Spatholobi Caulis alleviate disc degeneration by promoting autophagy in nucelus pulposus.

Cai S, Ding R, Zhang H, Chen Q, Yu F, Xia Y Mater Today Bio. 2024; 29:101323.

PMID: 39624051 PMC: 11609258. DOI: 10.1016/j.mtbio.2024.101323.


The most influential articles on stem cells in intervertebral disc degeneration.

Ye S, Chen R, Shi J, Wu Y BMC Musculoskelet Disord. 2024; 25(1):116.

PMID: 38331829 PMC: 10851499. DOI: 10.1186/s12891-024-07253-z.


Oxidative Stress in Ageing and Chronic Degenerative Pathologies: Molecular Mechanisms Involved in Counteracting Oxidative Stress and Chronic Inflammation.

Leyane T, Jere S, Houreld N Int J Mol Sci. 2022; 23(13).

PMID: 35806275 PMC: 9266760. DOI: 10.3390/ijms23137273.


Effect of Conditioned Medium from Human Umbilical Cord-Derived Mesenchymal Stromal Cells on Rejuvenation of Nucleus Pulposus Derived Stem/Progenitor Cells from Degenerated Intervertebral Disc.

Zeng X, Lin J, Wu H, Yu J, Tu M, Cheang L Int J Stem Cells. 2020; 13(2):257-267.

PMID: 32587132 PMC: 7378895. DOI: 10.15283/ijsc20027.


Current strategies for treatment of intervertebral disc degeneration: substitution and regeneration possibilities.

van Uden S, Silva-Correia J, Oliveira J, Reis R Biomater Res. 2017; 21:22.

PMID: 29085662 PMC: 5651638. DOI: 10.1186/s40824-017-0106-6.


References
1.
Meisel H, Ganey T, Hutton W, Libera J, Minkus Y, Alasevic O . Clinical experience in cell-based therapeutics: intervention and outcome. Eur Spine J. 2006; 15 Suppl 3:S397-405. PMC: 2335385. DOI: 10.1007/s00586-006-0169-x. View

2.
Seguin C, Grynpas M, Pilliar R, Waldman S, Kandel R . Tissue engineered nucleus pulposus tissue formed on a porous calcium polyphosphate substrate. Spine (Phila Pa 1976). 2004; 29(12):1299-306. DOI: 10.1097/01.brs.0000127183.43765.af. View

3.
Le Maitre C, Freemont A, Hoyland J . Localization of degradative enzymes and their inhibitors in the degenerate human intervertebral disc. J Pathol. 2004; 204(1):47-54. DOI: 10.1002/path.1608. View

4.
Le Maitre C, Hoyland J, Freemont A . Studies of human intervertebral disc cell function in a constrained in vitro tissue culture system. Spine (Phila Pa 1976). 2004; 29(11):1187-95. DOI: 10.1097/00007632-200406010-00006. View

5.
Horner H, Roberts S, Bielby R, Menage J, Evans H, Urban J . Cells from different regions of the intervertebral disc: effect of culture system on matrix expression and cell phenotype. Spine (Phila Pa 1976). 2002; 27(10):1018-28. DOI: 10.1097/00007632-200205150-00004. View